145 related articles for article (PubMed ID: 2591469)
1. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
[TBL] [Abstract][Full Text] [Related]
2. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
[TBL] [Abstract][Full Text] [Related]
3. Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers.
Girre C; Thomas G; Scherrmann JM; Crouzette J; Fournier PE
Fundam Clin Pharmacol; 1989; 3(5):537-43. PubMed ID: 2606428
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.
Achtert G; Scherrmann JM; Christen MO
Eur J Drug Metab Pharmacokinet; 1989; 14(4):317-22. PubMed ID: 2633927
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
[TBL] [Abstract][Full Text] [Related]
7. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
Weinling E; Sandouk P; Debray M; Scherrmann JM
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
[TBL] [Abstract][Full Text] [Related]
8. Colchicine disposition in patients with familial Mediterranean fever with renal impairment.
Ben-Chetrit E; Scherrmann JM; Zylber-Katz E; Levy M
J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.
Sandouk P; Chappey O; d'Yvoire MB; Scherrmann JM
Ther Drug Monit; 1995 Oct; 17(5):544-8. PubMed ID: 8585121
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.
Grevel J; Nüesch E; Abisch E; Kutz K
Eur J Clin Pharmacol; 1986; 31(2):211-6. PubMed ID: 3803418
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of colchicine: a review of experimental and clinical data.
Sabouraud A; Rochdi M; Urtizberea M; Christen MO; Achtert G; Scherrmann JM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():35-9. PubMed ID: 1449014
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of methyprylon following a single oral dose.
Gwilt PR; Pankaskie MC; Thornburg JE; Zustiak R; Shoenthal DR
J Pharm Sci; 1985 Sep; 74(9):1001-3. PubMed ID: 2866242
[TBL] [Abstract][Full Text] [Related]
14. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.
Reymond JP; Steimer JL; Niederberger W
J Pharmacokinet Biopharm; 1988 Aug; 16(4):331-53. PubMed ID: 3193363
[TBL] [Abstract][Full Text] [Related]
15. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
[TBL] [Abstract][Full Text] [Related]
16. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.
Rudi J; Raedsch R; Gerteis C; Schlenker T; Plachky J; Walter-Sack I; Sabouraud A; Scherrmann JM; Kommerell B
Scand J Gastroenterol; 1994 Apr; 29(4):346-51. PubMed ID: 8047810
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
18. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of baclofen derived from intestinal infusion.
Kochak GM; Rakhit A; Wagner WE; Honc F; Waldes L; Kershaw RA
Clin Pharmacol Ther; 1985 Sep; 38(3):251-7. PubMed ID: 4028618
[TBL] [Abstract][Full Text] [Related]
20. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
